Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04903119
Title Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Peng Wang, MD PhD
Indications

melanoma

Therapies

Dabrafenib + Nilotinib + Trametinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Markey Cancer Center Recruiting Lexington Kentucky 40536 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field